Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

The combination therapy was effective and well-tolerated, especially in young patients.

The new drug carriers show promise for better targeting and treating ovarian cancer.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Lasers can help reduce skin side effects from cancer treatment.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Cancer treatments often cause skin, nail, and hair problems.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Nilotinib can cause skin issues like red bumps and hair loss.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.